Volume 42, Issue 8 pp. 1861-1871
ORIGINAL ARTICLE

Migration rate using fully covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT study group

Rita Conigliaro

Rita Conigliaro

Azienda Ospedaliero Universitaria - Ospedale Civile di Baggiovara, Modena, Italy

Search for more papers by this author
Flavia Pigò

Corresponding Author

Flavia Pigò

Azienda Ospedaliero Universitaria - Ospedale Civile di Baggiovara, Modena, Italy

Correspondence

Flavia Pigò, Endoscopy Unit, S. Agostino Estense Civil Hospital, Viale Giardini 1355, 41 126, Modena, Italy.

Email: [email protected]

Search for more papers by this author
Helga Bertani

Helga Bertani

Azienda Ospedaliero Universitaria - Ospedale Civile di Baggiovara, Modena, Italy

Search for more papers by this author
BASALT Group:Salvatore GrecoCesare BurtiAmedeo IndrioloAntonio Di SarioAlessio OrtolaniLuca MaroniAndrea TringaliFederico BarbaroGuido CostamagnaAndrea MagarottoEnzo MasciMassimiliano MutignaniEdoardo FortiAlberto TringaliMaria C. ParodiLorenzo AssandriCiro MarroneAlberto FantinRoberto PenaginiPaolo CantùLiver Transplant Centers:

Liver Transplant Centers:

Search for more papers by this author
Fabrizio Di BenedettoPaolo RavelliMarco VivarelliSalvatore AgnesVincenzo MazzaferroLuciano De CarlisEnzo AndornoUmberto CilloGiorgio Rossi
First published: 17 March 2022
Citations: 1

The BASALT Group members and Liver Transplant Centers members are listed in the Appendix section.

Handling editor: Luca Valenti

Abstract

Background and Study Aim

The traditional endoscopic therapy of anastomotic strictures (AS) after orthotopic liver transplantation (OLT) is multiple ERCPs with the insertion of an increasing number of plastic stents side-by-side. Fully covered self-expanding metal stents (cSEMS) could be a valuable option to decrease the number of procedures needed or non-responders to plastic stents. This study aims to retrospectively analyse the results of AS endoscopic treatment by cSEMS and to identify any factors associated with its success.

Patients and Methods

Ninety-one patients (mean age 55.9 ± 7.6 SD; 73 males) from nine Italian transplantation centres, had a cSEMS positioned for post-OLT-AS between 2007 and 2017. Forty-nine (54%) patients were treated with cSEMS as a second-line treatment.

Results

All the procedures were successfully performed without immediate complications. After ERCP, adverse events occurred in 11% of cases (2 moderate pancreatitis and 8 cholangitis). In 49 patients (54%), cSEMSs migrated. After cSEMS removal, 46 patients (51%) needed further endoscopic (45 patients) or radiological (1 patient) treatments to solve the AS. Lastly, seven patients underwent surgery. Multivariable stepwise logistic regression showed that cSEMS migration was the only factor associated with further treatments (OR 2.6, 95% CI 1.0–6.6; p value 0.03); cSEMS implantation before 12 months from OLT was associated with stent migration (OR 5.2, 95% CI 1.7–16.0; p value 0.004).

Conclusions

cSEMS appears to be a safe tool to treat AS. cSEMS migration is the main limitation to its routinary implantation and needs to be prevented, probably with the use of new generation anti-migration stents.

CONFLICT OF INTEREST

Conflict of interest was declared by the authors.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available owing to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.